Brief: InDex Pharmaceuticals Q3 EBIT SEK -42.1 Million
28/11/2023 07:01
Nov 28 (Reuters) - InDex Pharmaceuticals Q3 sales SEK 0. * Q3 net income SEK -37.9 million * Q3 cash flow from operating activities SEK -47.8 million * Q3 adjusted EPS SEK -0.07
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen